Your Article Summary
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin (Human Growth Hormone)
Teva Pharmaceutical Industries, 07/01/09
Teva Pharmaceutical Industries Ltd. and its partner, Antares Pharma, Inc. announced the approval of a Supplemental New Drug Application, which added "needle-free injection" to its Tev-Tropin brand human growth hormone drug label. Teva will market the Antares needle-free device as the Tev-Tropin Tjet Injector system.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Article Search
Sponsor


See Latest Articles


